Michigan Attorney General Bill Schuette says the state is in line to get $23.8 million as part of a $3 billion settlement of an improper drug marketing case against GlaxoSmithKline LLC.
The U.S. Justice Department said Monday that the British pharmaceutical giant agreed to the payment and is pleading guilty to promoting two popular drugs for unapproved uses.
The federal government says the company also admits failing to disclose important safety information on a third drug.
Michigan was among states that sued the company.
Schuette says GlaxoSmithKline underpaid the rebates in owed for drugs paid through Michigan's Medicaid program.
The Justice Department says the $3 billion combined criminal-civil fine will be the largest penalty ever paid by a drug company.